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BACKGROUND: Vitamin D plays essential role in the regulation of inflammation, such as in pathogenesis of Juvenile Idiopathic Arthritis (JIA). 
Vitamin D deficiency has been reported among JIA patients, 
but there were conflicting results regarding the correlation 
with disease activity. This study aimed to assess vitamin 
D serum level and its correlation with C-Reactive Protein 
(CRP) and disease activity in JIA patients.
METHODS: Children who were diagnosed with JIA 
according to International League of Associations for 
Rheumatology (ILAR) criterias were enrolled as JIA group 
subjects, while age and sex-matched healthy children were 
enrolled as the control group subjects. Vitamin D and CRP 
serum level were measured. Disease activity of JIA patients 
was calculated by Juvenile Arthritis Disease Activity 
Score-27 (JADAS-27).
RESULTS: Vitamin D serum level was lower in the JIA 
group compared to the healthy control group (p=0.000). 
Among 26 JIA patients, 61.5% were deficient, 30.8% were 
insufficient, and 7.7% had normal vitamin D. No significant 
different in CRP level between vitamin D group (p=0.441), 
but there was significant different in JADAS-27 (p=0.001). 
The mean of CRP and JADAS-27 were found highest in 
vitamin D deficiency group. Vitamin D serum level was 
negatively correlate with CRP (p=0.021, r=-0.452) and 
JADAS-27 (p=0.001 r=-0.595).
CONCLUSION: Low level of vitamin D in JIA patients 
was inversely related to higher CRP and disease activity, 
suggesting that vitamin D supplementation could be have 
potential role in JIA treatment.
KEYWORDS: vitamin D, CRP, disease activity, 
JADAS-27, JIA
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Abstract
Introduction
In recent decades, it has been established that vitamin D 
plays an important role in the regulation of inflammation, 
thus implicating vitamin D deficiency in the pathogenesis 
of several autoimmune and chronic rheumatic diseases.
(1) Juvenile idiopathic arthritis (JIA) is an autoimmune, 
chronic inflammatory joint disease and is the most common 
type of arthritis in children.(2) It causes persistent joint pain, 
swelling, and stiffness and often leads to substantial long-
term morbidity and physical disability.(3) 
 The International League of Associations for 
Rheumatology (ILAR) criteria define JIA as arthritis that 
arises before 16 years of age and persists for at least six 
weeks, with the exclusion of other known conditions.(4) 
Several studies have reported low levels of vitamin D in 
children with JIA (5-7), and it has been suggested that low 
vitamin D levels are correlated with higher disease activity 
(8). A cohort study conducted in children with JIA showed 
that a low level of vitamin D was associated with higher 
disease activity and increased risk of developing uveitis.(9) 
A similar study performed in Turkey reported that vitamin 
D was negatively correlated with disease activity in JIA 
patients.(10) 
 Several recent publications have highlighted the 
potential role of vitamin D in regulating inflammation. 
According to a study conducted in Kuwait, JIA patients 
with vitamin D deficiency and high C-reactive protein 
(CRP) levels produced significantly higher levels of 
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proinflammatory cytokines such as tumor necrosis factor 
(TNF)-α and interleukin (IL)-8 than subjects with low CRP 
levels.(11) CRP is an acute-phase protein produced by the 
liver that increases in response to inflammation. Further, the 
ratios of anti-inflammatory/pro-inflammatory cytokines in 
patients with low levels of CRP suggest that vitamin D plays 
a role in maintaining an anti-inflammatory environment, as 
the ratios are higher in patients with nondeficient vitamin 
D levels than in patients deficient in vitamin D. These data 
point to a possible role for vitamin D in the regulation 
of inflammation.(11) However, other studies found no 
correlation between vitamin D levels and JIA subtypes 
or disease activity.(12-15) A meta-analysis revealed that 
vitamin D supplementation had no effect on CRP and 
pro-inflammatory cytokines.(16) Given these conflicting 
results, it is essential to understand the role of vitamin D in 
JIA to optimize the management of JIA patients. This is the 
first study in Indonesia concerning vitamin D and disease 
activity in children with JIA. This study aimed to assess 
vitamin D serum levels and their correlation with CRP and 
disease activity in patients with JIA in Indonesia. 
Methods
Research Subjects
This study was conducted between January 2017 and 
December 2019 at the Pediatric Allergy and Immunology 
Department at Saiful Anwar Hospital, Malang, Indonesia. 
Children aged 5-16 years who were diagnosed with JIA 
and had routine clinical monitoring at Saiful Anwar 
Hospital were enrolled. The ILAR classifies JIA patients 
into different subtypes, including oligoarthritis, rheumatoid 
factor-positive polyarthritis, rheumatoid factor-negative 
polyarthritis, and systemic-onset arthritis.(2) Subjects who 
had concurrent medical problems (malignancy, type 1 
diabetes, inflammatory bowel disease, autoimmune disease, 
and immunodeficiency), had a history of recent infection 
(within two weeks), or were using any medications that 
would affect vitamin D metabolism were excluded from 
this study. The healthy control group consisted of age- 
and sex-matched participants who were undergoing a 
routine health examination. This research was approved by 
Ethical Committee of the Faculty of Medicine, Brawijaya 
University, Indonesia (236/EC/KEPK/10/2017). 
Blood Sampling
Venous blood samples were collected into vacutainer tubes 
for complete blood count examination and serum analysis. 
The coagulated blood was centrifuged for 10 minutes at 
3,000 rpm; the serum was aliquoted into sterile tubes and 
stored frozen at -20°C until analysis. 
Measurement of Vitamin D and CRP
Serum vitamin D levels (25-hydroxy vitamin D; 25-(OH)
D) were measured by enzyme-linked immunosorbent assay 
(ELISA) with a commercial 25-OH Vitamin D Human ELISA 
Kit (NovaTeinBio, Greater Boston, USA). The presence 
of vitamin D antigen in the sample will captured with an 
antigen-specific antibody. The detection antibody then 
covalently attached to enzypme linked secondary antibody. 
Enzyme substrate was then added to the wells producing a 
visible signal that is correlated with the amount of antigen 
and measured by a spectrophotometer. Vitamin D deficiency 
was defined as serum 25(OH)D<20 ng/mL, insufficiency as 
20-30 ng/mL, and sufficiency as >30 ng/mL.(17-19) The 
level of CRP in serum was measured using Cobas 6000 c501 
Chemistry Analyzer immunoenzymometric assay (Roche 
Diagnostics, Holliston, USA). It used a single immunological 
reaction between CRP and peroxidase labeled antibody with 
another antibody attached to the wall of the test tube. The 
immune complex formed was determined by a colorimetric 
assay using a peroxidase substrate. The normal level of CRP 
in human serum was 2 mg/L, whereas during inflammatory 
conditions, its concentration rises significantly.
Measurement of Disease Activity
Disease activity measurement in JIA patients was assessed 
using the Juvenile Arthritis Disease Activity Score 
(JADAS)-27. This score includes four measures: global 
physician assessment of disease activity using a visual 
analog scale (VAS), global parent assessment of child’s 
well-being determined using a VAS, count of joints with 
active disease, and erythrocyte sedimentation rate (ESR). 
The physician assessment of disease activity was based on 
a 10-cm VAS, where 0 corresponded to no activity and ten 
corresponded to maximum activity. The parent’s assessment 
of the child’s well-being was based on another 10-cm VAS 
in which 0 corresponded to very well and 10 to very poor. 
The count of active joints in JADAS-27 evaluated 27 joints: 
cervical spine, elbows, wrists, metacarpophalangeal joints 
(from first to third), proximal interphalangeal joints, hips, 
knees, and ankles. Each active joint scored 1 point, and 
the total ranges from 0 to 27. ESR was normalized to a 
score ranging from 0 to 10 using the formula (ESR-20)/10. 
JADAS-27 was then calculated as the simple linear sum 
of the scores of its four components, which yields a total 
score of 0 to 57, with higher scores representing worse 
151
DOI: 10.18585/inabj.v12i2.1143 Vitamin D, CRP and Disease Activity in JIA (Wulandari D, et al.)Indones Biomed J. 2020; 12(2): 149-156
disease activity.(20) The cutoffs for disease activity states 
based on JADAS-27 for oligoarthritis were inactive disease 
≤1, low disease activity 1.1–2, moderate disease activity 
2.1–4.2, high disease activity >4.2; while for polyarthritis 
and systemic-onset arthritis were inactive disease ≤1, low 
disease activity 1.1–3.8, moderate disease activity 3.9–8.5, 
high disease activity >8.5.(21)
Statistical Analysis
Data analyses were performed using the software program 
SPSS Statistics, version 25.0 (IBM Corporation, New York 
City, USA). The p-values≤0.05 were considered significant. 
Descriptive statistics are reported as mean±standard 
deviation. Comparative analysis of parameters between the 
JIA and control groups was performed using the independent 
t-test and chi-square test for parametric data and the Mann–
Whitney test for non-parametric data. Statistical analysis 
comparing parameters between the vitamin D groups 
was conducted using analysis of variance (ANOVA) for 
parametric data and the Mann–Whitney test for non-
parametric data. The Pearson correlation test was used 
to analyze the associations between vitamin D, CRP, and 
JADAS-27. A multivariate linear regression analysis was 
performed to analyze the association between JADAS-27 
and potential confounders.
Results
Fifty-one subjects including 20 boys and 31 girls, aged 
12.29±2.02 years old, were included in this study. There 
were 26 patients in the JIA group and 25 participants in the 
healthy control group. The demographic characteristics of 
the subjects are shown in Table 1. There was no difference 
in sex distribution or age between the groups. There was a 
higher incidence of underweight nutritional status in the JIA 
group compared to the control group. From the complete 
blood count analysis, the mean leukocyte and thrombocyte 
counts were higher in the JIA group.
 There was a lower mean level of serum vitamin D 
in the JIA group compared to the healthy control group, 
18.94±7.87 ng/mL and 27.38±6.39 ng/mL (p=0.000). 
Among JIA group, vitamin D deficiency insufficiency were 
found in 16 (61.5%) and 8 (30.8%) subjects, respectively. 
Only 2 (7.7%) subjects were found to have adequate vitamin 
D levels. In the healthy control group, only 2 (8%) subjects 
had vitamin D deficiency, 10 (40%) subjects had vitamin D 
insufficiency, and 13 (52%) subjects had sufficient levels of 
vitamin D.
 Regarding JIA subtypes, there were 12 (46.1%) 
subjects with oligoarthritis, 8 (30.75%) subjects with 
Parameters JIA Group (n=26)
Healthy Control 
Group (n=25) p -value
#Sex, n
    Female 15 16
    Male 11 9
$Age (years old) 12.92±1.62 10.65±2.08 0.052
#Nutritional status, n
    Well nourish 9 20
    Underweight 17 5
Laboratory results 
    $Hemoglobin levels (g/dL) 11.79±1.62 12.45±0.69 0.064
    $White blood cell count (mm3) 9537.69±2674.58 7965.2±1271.32 0.011*
    $Thrombocyte count x103 (/mm3) 401.73±107.54 282.04±68.54 0.000*
    $Vitamin D serum level (ng/mL) 18.94±7.87 27.38±6.39 0.000*
    $CRP serum level (mg/L) 3.34±3.65 0.72±0.57 0.000*
Classification of vitamin D, n
    Deficiency (<20 ng/mL) 16 2
    Insufficiency (20-30 ng/mL) 8 10
    Sufficiency (>30 ng/mL) 2 13
0.645
0.001*
Table 1. Characteristics of study participants.
Results are expressed as frequency and mean±SD. #Tested with Chi-Square Test; $Tested with Independent 
T-test; *p<0.05 was considered significant.
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Figure 1. Location of affected joint in JIA patients. Data are expressed as frequency (%). MCP: metacarpophalangeal joints, PIP: 
proximal interphalangeal.
Table 2. JADAS-27 measurement in JIA patients (n=26).
Parameters Value
JADAS-27 component
    Patient’s VAS 4.58±1.24
    Physician’s VAS 4.31±1.05
    Joint count 3.88±2.32
    ESR normalized 1.37±1.18
    Total JADAS-27 14.14±4.24
JADAS-27 in each JIA subtypes
    Oligoarthritis (n=12) 11.07±2.07
    RF-positive polyarthritis (n=8) 17.95±4.33
    RF-negative polyarthritis (n=5) 14.54±2.32
    Systemic arthritis (n=1) 18.6
Classification of JADAS-27, n
    Inactive disease 0
    Low disease activity 0
    Moderate disease activity 0
    High disease activity 26 (100%)
Results are expressed as mean±SD and frequency (%). 
JADAS-27: Juvenile Arthritis Disease Activity Score 27; VAS: 
Visual Analog Scale; ESR: Erythrocyte Sedimentation Rate; 
JIA: Juvenile Idiopathic Arthritis; RF: Rheumatoid factor.
rheumatoid factor-positive polyarthritis, 5 (19.2%) subjects 
with rheumatoid factor-negative polyarthritis, and 1 (3.8%) 
subject with systemic arthritis. The most common clinical 
manifestation in JIA patients was arthritis, followed by 
fever and skin rash. The number of involved joints varied 
from 1–22 joints. The most commonly affected joints were 
the knee, wrist, and ankle (Figure 1). Six (23.1%) subjects 
were receiving only nonsteroidal anti-inflammatory drugs 
(NSAIDs) as treatment, 11 (42.3%) subjects were using a 
combination of NSAIDs and corticosteroid, and 9 (34.6%) 
subjects were taking disease-modifying anti-rheumatic 
drugs (DMARDs) such as methotrexate in addition to 
NSAIDs and corticosteroid. 
 The average JADAS-27 score was 14.14±4.24 (range 
8.00-24.40). Based on the JADAS-27 scores, all JIA subjects 
in this study were considered to have active disease and 
high disease activity. The highest JADAS-27 scores were 
found in subjects with systemic arthritis. The components 
of JADAS-27 (patient’s VAS, physician’s VAS, joints with 
active disease, ESR) and disease activity classification are 
described in Table 2. JADAS-27 scores were significantly 
different among the three groups divided by vitamin D levels 
(p=0.001). JADAS-27 scores were highest in the vitamin D 
deficiency group and lowest in the sufficiency group (Figure 
2). There was a statistically significant negative correlation 
between vitamin D levels and JADAS-27 scores (p=0.001, 
r=-0.595).
 We also examined the correlation between vitamin 
D serum levels with JADAS-27 components. There were 
statistically significant negative correlations between 
vitamin D serum levels and the patient’s VAS and physician’s 
VAS (p=0.001 and p=0.000, respectively). No association 
was found between vitamin D serum levels and affected 
joint count or ESR (p=0.116 and p=0.127, respectively). 
 Serum CRP levels were elevated in JIA patients 
compared to healthy control subjects (3.34±3.65 mg/L vs. 
0.72±0.57 mg/L, p=0.000) (Table 1). No difference was 
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found between the CRP serum levels among vitamin D 
group (p=0.441). But the mean of CRP serum level was 
highest in the vitamin D deficiency group and lowest in 
the sufficiency group (Figure 3). There was also significant 
inverse correlation between vitamin D and CRP serum level 
(p=0.021, r=-0.452). CRP is an inflammatory marker that 
increased in chronic inflammatory condition such as in 
JIA. We found a significant positive association between 
CRP serum level and JADAS-27 (p=0.016, r=0.468). The 
correlation between vitamin D, CRP and disease activity in 
JIA patients can be found in Figure 4. In multivariate linear 
regression analysis, a similar association was found after 
adjusting for age, BMI and thrombocyte count (p=0.014 
for vitamin D, p=0.027 for CRP and  p>0.05 for other 
parameters).  
20
15
10
5
0
JA
D
A
S-
27
16.25±3.94
11.26±1.68
8.80±1.13
Vitamin D Group
Deficiency            Insufficiency           Sufficiency
Figure 2. Comparison of JADAS-27 in different vitamin D 
classification. ANOVA and Post Hoc test were used to analyze the 
different of mean the JADAS-27 in each group.
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Figure 3. Comparison of CRP serum level in different vitamin 
D classification. ANOVA and Post Hoc test were used to analyze 
the different of mean the CRP in each group. 
Discussion
In this study, there were 26 JIA patients enrolled in three 
years of observation. Among the patients, 57.6% were girls 
and 42.4% were boys, with the mean age was 12.92±1.62 
years old, which is not substantially different from other 
studies.(22) A previous study reported that 28 patients with 
JIA were seen at the Dr. Hasan Sadikin General Hospital 
in Bandung Indonesia between January 2006 and October 
2011, which is consisted of 10 boys and 18 girls with ages 
ranging from 2 to 14 years.(23) We found that the majority 
of patients with JIA had the oligoarthritis subtype, followed 
by rheumatoid factor-positive polyarthritis and that the most 
commonly affected joints were the knee, wrist, and ankle. 
Similar studies in the USA, Germany, Brazil, Morocco, 
and Turkey also reported that oligoarticular JIA is the most 
common JIA subtype.(9-13) There was a high incidence 
of underweight nutritional status in patients with JIA in 
our study. There seems to be an independent association 
between being underweight and higher disease activity 
in JIA patients.(24) A cross-sectional study conducted in 
Norway showed that there was no difference in height or 
BMI between JIA patients and healthy subjects. However, 
a significantly reduced BMI was observed in female JIA 
patients with the systemic disease compared to those with 
oligoarticular JIA. In addition, female JIA patients who 
had been using corticosteroids had significantly lower 
weight, height, and BMI than patients who had never used 
corticosteroids.(25) Importantly, these results suggest that 
JIA could impair a child’s nutritional status.
 There was a low level of vitamin D in the group of 
JIA patients compared to the age- and sex-matched control 
group. Several other studies also reported that there were 
low levels of vitamin D in children with JIA compared to 
healthy control subjects.(6,10,26) However, a meta-analysis 
including 19 studies reporting values of 25(OH)D and 
1,25(OH)D in patients with JIA could not find evidence to 
link vitamin D deficiency with JIA due to the lack of cut-
off criteria of vitamin D deficiency in pediatric populations.
(5,17) The American Academy of Pediatrics recommended 
that serum concentrations of 25(OH)D should be maintained 
above 20 ng/mL in children, but it did not establish the 
values to distinguish between sufficiency and insufficiency.
(18) The Endocrine Society has published guidelines stating 
that the optimal 25(OH)D concentration in children is above 
75 nmol/L (30 ng/mL).(19) The South East Asian Nutrition 
Surveys (SEANUTS), a cross-sectional nutritional survey 
including four South East Asian countries, reported that the 
mean level of 25(OH)D in Indonesian children aged 0.5 to 
12 years was 52.7 nmol/L (21.08 ng/mL). There was not 
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Figure 4. Correlation between Vitamin D, 
CRP and disease activity in JIA patients. A: 
correlation between CRP levels and JADAS-27 
scores; B: correlation between vitamin D levels 
and JADAS-27 scores; C: correlation between 
CRP levels and JADAS-27 scores.
yet a standard classification of sufficient, insufficient, and 
deficient vitamin D levels.(27) A previous study conducted 
in Jakarta, Indonesia, involving 120 children aged 7-12 
years from two different elementary schools used three 
classifications of 25(OH)D levels: sufficient if ≥32 ng/dL, 
insufficient if between 15 and 31 ng/dL, and deficient if 
<15 ng/dL.(28)  Prior to this study, no studies had reported 
vitamin D levels in JIA patients in Indonesia. 
 It has been established that vitamin D has an 
essential role in the pathogenesis of autoimmune and 
rheumatic diseases.(29) These effects can be achieved 
only if (1,25(OH)2D), the active form of vitamin D that is 
generated from circulating 25-hydroxyvitamin D (25(OH)
D), is bound to the vitamin D receptor (VDR). VDR 
then binds to the vitamin D response element to activate 
the transcription of genes that regulate the inflammatory 
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response. Vitamin D could inhibit the differentiation and 
maturation of human dendritic cells; suppress T helper 1 
(Th1 and Th17 proliferation; promote Th2 and T regulatory 
cell proliferation; inhibit the synthesis, secretion, and release 
of pro-inflammatory cytokines; and induce the production 
of anti-inflammatory cytokines.(30) Consequently, low 
vitamin D concentrations are associated with higher disease 
severity in JIA. 
 A previous study showed that subjects with deficient 
levels of vitamin D produced higher levels of CRP and pro-
inflammatory cytokines.(31) A meta-analysis reported that 
vitamin D supplementation had no effect on serum CRP 
and inflammatory cytokines.(16) In the present study, there 
was a high CRP serum level in JIA patients and a positive 
correlation between CRP levels and JADAS-27 scores; 
thus, high CRP levels were associated with high JADAS-27 
scores. The American College of Rheumatology developed 
consensus guidelines for JIA treatment, including the use 
of CRP and ESR as biomarkers. A high CRP level, greater 
than twice the upper limit of normal, is considered a poor 
prognostic indicator in patients with JIA.(32) A cross-
sectional study conducted in Turkey found that a low level 
of vitamin D correlates with high disease activity in JIA 
patients.(10) Other studies also confirmed that JIA patients 
with active disease or frequent relapses had significantly 
lower levels of 25(OH)D compared to patients with no active 
disease or infrequent flares.(26) In contrast with our results, 
other studies reported no correlation between vitamin D 
level and JIA subtypes or disease activity.(11,13) A similar 
study reported that the vitamin D serum levels in children 
with JIA were significantly lower than those of healthy 
children, but there was no significant difference between 
vitamin D levels during active JIA and JIA in remission. 
They also found no significant correlation between disease 
activity and serum vitamin D levels.(6) A case-control study 
in China also reported no correlation between vitamin D 
serum level and JIA subtypes, CRP and ESR.(14) A study 
examining serum 25(OH)D levels and disease activity in 
children and adolescents in the US with JIA performed 
also found no association between vitamin D and disease 
activity.(15) These different results may be due to different 
methodological approaches, the different geographic regions 
studied, and the demographically disparate populations.(2) 
The limitations of the present study are relatively small 
sample size, single-center study and there was no data 
about dietary intake of vitamin D, daily topical sunscreen 
utilization, daily physical activities, and degree of exposure 
to the sun, all of which may affect vitamin D levels and a 
dose of treatment. Therefore, further studies are needed to 
confirm our findings.
Conclusion
In conclusion, the frequencies of vitamin D deficiency and 
insufficiency were considerably high among patients with 
JIA. Vitamin D had inverse correlation between with CRP 
and disease activity in JIA patients. Therefore, clinicians 
should be aware of vitamin D deficiencies in JIA patients 
and to consider vitamin D supplementation as an adjunctive 
treatment in JIA.
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